Table 3 Multiple regression analysis for E/E′ and related parameters

From: The balance of fetuin-A and osteoprotegerin is independently associated with diastolic dysfunction in hemodialysis patients

 

With baPWV

Without baPWV

 

β

t

P

β

t

P

Model 1

 Fetuin-A

−0.325

−2.308

0.026

−0.298

−2.230

0.031

 Age

0.168

1.181

0.244

0.096

1.181

0.244

 Sex (M=1)

−0.268

−1.953

0.057

−0.261

−1.953

0.057

 Duration of dialysis

0.067

0.468

0.642

0.089

0.468

0.642

 Mean BP

−0.151

−1.062

0.294

−0.098

−1.062

0.294

 Heart rate

−0.990

−0.638

0.527

−0.015

−0.638

0.527

 BMI

−0.121

−0.852

0.399

−0.055

−0.852

0.399

 Hemoglobin

−0.020

−0.135

0.894

−0.005

−0.135

0.894

 Smoking

0.037

0.260

0.796

−0.004

0.260

0.796

 Medication for hypertension

0.171

1.211

0.232

0.148

1.211

0.232

 Medication for diabetes

0.140

0.969

0.338

0.098

0.969

0.338

 Medication for dyslipidemia

0.192

1.160

0.080

0.251

1.160

0.080

 Prior coronary artery disease

0.062

0.468

0.642

0.038

0.468

0.642

 BNP

0.252

1.892

0.059

0.339

2.537

0.015

 baPWV

0.344

2.551

0.015

Model 2

 Osteoprotegerin

0.367

2.563

0.010

0.404

2.995

0.004

 Age

0.148

1.043

0.303

0.080

1.043

0.573

 Sex (M=1)

−0.258

−2.088

0.063

−0.263

−2.005

0.068

 Duration of dialysis

−0.204

−1.151

0.256

−0.178

−1.151

0.303

 Mean BP

−0.153

−1.092

0.281

−0.071

−1.092

0.620

 Heart rate

−0.151

−1.068

0.291

−0.124

−1.068

0.369

 BMI

−0.053

−0.373

0.711

−0.019

−0.373

0.891

 Hemoglobin

−0.050

−0.346

0.731

−0.005

−0.346

0.973

 Smoking

0.052

0.368

0.715

0.122

0.368

0.380

 Medication for hypertension

0.207

1.508

0.139

0.184

1.508

0.171

 Medication for diabetes

0.244

1.789

0.080

0.186

1.789

0.178

 Medication for dyslipidemia

0.204

1.484

0.145

0.138

1.484

0.321

 Prior coronary artery disease

0.153

1.098

0.278

0.104

1.098

0.450

 BNP

0.282

2.000

0.052

0.263

2.000

0.059

 baPWV

0.273

1.432

0.159

Model 3

 OPG/fetuin-A

0.295

2.071

0.044

0.275

1.934

0.048

 Age

0.162

1.114

0.303

0.105

0.737

0.465

 Sex (M=1)

−0.243

−1.810

0.068

−0.258

−1.888

0.058

 Duration of dialysis

−0.094

−0.547

0.256

−0.012

−0.073

0.942

 Mean BP

−0.138

−0.960

0.281

−0.086

−0.608

0.546

 Heart rate

−0.143

−0.966

0.291

−0.086

−0.592

0.557

 BMI

−0.068

−0.470

0.711

−0.016

−0.112

0.911

 Hemoglobin

−0.053

−0.353

0.731

−0.050

−0.352

0.727

 Smoking

0.067

0.462

0.715

0.020

0.141

0.888

 Medication for hypertension

0.199

1.413

0.139

0.178

1.307

0.198

 Medication for diabetes

0.205

1.459

0.120

0.165

1.200

0.237

 Medication for dyslipidemia

0.243

1.742

0.145

0.207

1.520

0.136

 Prior coronary artery disease

0.127

0.891

0.278

0.101

0.728

0.470

 BNP

0.297

2.189

0.034

0.311

2.213

0.032

 baPWV

0.284

1.905

0.063

  1. Abbreviations: β, β coefficient; baPWV, brachial–ankle pulse wave velocity; BMI, body mass index; BNP, brain natriuretic peptide; BP, blood pressure; OPG, osteoprotegerin.
  2. Model 1, F ratio=6.243; r2=0.221 (P=0.004) with baPWV, F ratio=6.203; r2=0.220 (P=0.004) without baPWV.
  3. Model 2, F ratio=6.571; r2=0.219 (P=0.004) with baPWV, F ratio=6.176; r2=0.210 (P=0.008) without baPWV.
  4. Model 3, F ratio=4.780; r2=0.178 (P=0.013) with baPWV, F ratio=4.782; r2=0.188 (P=0.010) without baPWV.